Rendering

Component: (Network and Table)
Network
2308301 - Disclosure - Income Tax (Tables)
(http://www.intralinks.com/role/IncomeTaxTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Income Tax Disclosure [Abstract]Period [Axis]
2015-01-01 - 2015-12-31
Income Tax Disclosure [Abstract]
 
Schedule of income before income tax, domestic and foreign
The following is a summary of the Company's U.S. and non-U.S. net (loss) income before income tax:
 
Years Ended December 31,
  
2015
 
2014
 
2013
 
(In thousands)
U.S.
$
(34,567
)
 
$
(33,079
)
 
$
(25,741
)
Non-U.S.
5,028

 
4,818

 
5,114

Net loss before income tax
$
(29,539
)
 
$
(28,261
)
 
$
(20,627
)
 
 
Schedule of components of income tax expense
The components of the Company's income tax expense (benefit) are as follows:
 
Years Ended December 31,
  
2015
 
2014
 
2013
 
(In thousands)
Current: 
 
 
 
 
 
Federal
$
63

 
$
181

 
$
220

State and local
12

 
(42
)
 
626

Foreign
1,727

 
2,804

 
2,143

Total current income tax expense
1,802

 
2,943

 
2,989

 
 
 
 
 
 
Deferred:
 
 
 
 
 
Federal
(387
)
 
(4,248
)
 
(6,640
)
State and local
(56
)
 
(487
)
 
(1,483
)
Foreign
(514
)
 
27

 
(215
)
Total deferred income tax benefit
(957
)
 
(4,708
)
 
(8,338
)
Total income tax expense (benefit)
$
845

 
$
(1,765
)
 
$
(5,349
)
 
 
Schedule of effective income tax rate reconciliation
A reconciliation of the provision for income taxes at the U.S. Federal statutory income tax rate of 35% to the Company's effective income tax rate is as follows:
 
Years Ended December 31,
  
2015
 
2014
 
2013
 
(In thousands)
Tax at U.S. Federal statutory rate of 35%
$
(10,339
)
 
$
(9,891
)
 
$
(7,219
)
State taxes, net of federal income tax effect
(1,987
)
 
(1,186
)
 
(557
)
Stock-based compensation expense
211

 
622

 
1,886

Non-deductible expenses
1,251

 
759

 
438

Foreign taxes
795

 
2,043

 
1,348

Research and development credit
(984
)
 
(647
)
 
(1,008
)
Other
138

 
88

 
(237
)
Valuation allowance
11,760

 
6,447

 

Total income tax expense (benefit)
$
845

 
$
(1,765
)
 
$
(5,349
)
Effective tax rate
(2.9
)%
 
6.2
%
 
25.9
%
 
 
Schedule of deferred tax assets and liabilities
Following is a summary of the components of deferred tax assets and deferred tax liabilities at December 31, 2015 and 2014:
 
Years Ended December 31,
 
2015
 
2014
 
(In thousands)
Deferred tax assets:
 
 
 
Net operating loss carryforwards 
$
7,975

 
$
10,008

Research and development tax credit carryforwards
9,652

 
8,185

Stock-based compensation
6,723

 
5,529

Accrued expenses
4,629

 
4,108

AMT tax credit carryforwards
1,790

 
1,727

Allowance for doubtful accounts
1,660

 
1,264

Other
4,613

 
4,275

Total deferred tax assets
37,042

 
35,096

Valuation allowance
(19,576
)
 
(6,447
)
Deferred tax assets, net of valuation allowance
17,466

 
28,649

Deferred tax liabilities:
 
 
 
Depreciation and amortization
(16,952
)
 
(28,649
)
Total deferred tax liabilities
(16,952
)
 
(28,649
)
Net deferred tax assets, net of valuation allowance
$
514

 
$

 
 
Schedule of unrecognized tax benefits
The following table summarizes changes to the Company's unrecognized tax benefits, excluding interest and penalties:
 
Years Ended December 31,
 
2015
 
2014
 
2013
 
(In thousands)
Balance as of January 1
$
4,688

 
$
3,945

 
$
3,335

Additions based on tax positions related to the current year
685

 
540

 
389

Additions for prior year tax positions
168

 
289

 
221

Reductions from expirations of applicable statutes of limitations
(80
)
 
(86
)
 

Balance as of December 31
$
5,461

 
$
4,688

 
$
3,945